BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13963767)

  • 1. Clinical trials with leurosine methiodide, an alkaloid from Vinca rosea Linn.
    HODES ME; ROHN RJ; BOND WH; YARDLEY J
    Cancer Chemother Rep; 1963 Apr; 28():53-5. PubMed ID: 13963767
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine.
    JOHNSON IS; WRIGHT HF; SVOBODA GH; VLANTIS J
    Cancer Res; 1960 Aug; 20():1016-22. PubMed ID: 14407465
    [No Abstract]   [Full Text] [Related]  

  • 3. A note on several new alkaloids from Vinca rosea Linn. I. Leurosine, virosine, perivine.
    SVOBODA GH
    J Am Pharm Assoc Am Pharm Assoc; 1958 Nov; 47(11):834. PubMed ID: 13587332
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES ON CATHARANTHUS LANCEUS (VINCA LANCEA). I. ISOLATION OF LEUROSINE, PERIVINE, AND YOHIMBINE.
    FARNSWORTH NR; LOUB WD; BLOMSTER RN
    J Pharm Sci; 1963 Nov; 52():1114. PubMed ID: 14079649
    [No Abstract]   [Full Text] [Related]  

  • 5. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don). XV. Analysis of vinca alkaloids by thin-layer chromatography.
    CONE NJ; MILLER R; NEUSS N
    J Pharm Sci; 1963 Jul; 52():688-92. PubMed ID: 14022560
    [No Abstract]   [Full Text] [Related]  

  • 6. A note on the alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.). II. Catharanthine, lochnericine, vindolinine, and vindoline.
    GORMAN M; NEUSS N; SVOBODA GH; BARNES AJ; CONE NJ
    J Am Pharm Assoc Am Pharm Assoc; 1959 Apr; 48(4):256-7. PubMed ID: 13641069
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON CATHARANTHUS ALKALOIDS. 3. SEPARATION OF VINCALEUKOBLASTINE, LEUROCRISTINE, LEUROSINE AND LEUROSIDINE BY THIN-LAYER CHROMATOGRAPHY.
    FARNSWORTH NR; HILINSKI IM
    J Chromatogr; 1965 Apr; 18():184-8. PubMed ID: 14334202
    [No Abstract]   [Full Text] [Related]  

  • 8. Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.
    WARWICK OH; DARTE JM; BROWN TC; BEER CT; CUTTS JH; NOBLE RL
    Cancer Res; 1960 Aug; 20():1032-40. PubMed ID: 13842983
    [No Abstract]   [Full Text] [Related]  

  • 9. Catharanthus alkaloids, XXXVIII. Confirming structural evidence and antineoplastic activity of the bisindole alkaloids leurosine-N'b-oxide (pleurosine), roseadine and vindolicine from Catharanthus roseus.
    El-Sayed A; Handy GA; Cordell GA
    J Nat Prod; 1983; 46(4):517-27. PubMed ID: 6631435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [ANTINEOPLASTIC ALKALOIDS OF VINCA ROSEA LINN. (REVIEW OF THE LITERATURE)].
    KRASHILINA AIa
    Probl Gematol Pereliv Krovi; 1964 Dec; 9():26-33. PubMed ID: 14312105
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective deoxygenation of leurosine: concise access to anhydrovinblastine.
    Hardouin C; Doris E; Rousseau B; Mioskowski C
    J Org Chem; 2002 Sep; 67(18):6571-4. PubMed ID: 12201787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorimetric method for the determination of vinblastine, and alkaloid from Vinca rosea. I.
    JAKOVLJEVIC IM
    J Pharm Sci; 1962 Feb; 51():187-8. PubMed ID: 14036526
    [No Abstract]   [Full Text] [Related]  

  • 13. A COMPARISON OF CYTOLOGIC EFFECTS OF LEUROSINE METHIODIDE AND VINBLASTINE IN THE TISSUE CULTURE.
    PALMER CG; WARREN AK; SIMPSON PJ
    Cancer Chemother Rep; 1963 Sep; 31():1-2. PubMed ID: 14066228
    [No Abstract]   [Full Text] [Related]  

  • 14. Catharanthus alkaloids XXXIII. 21'Oxo-leurosine from Catharanthus roseus (apocynaceae).
    El-Sayed A; Handy GA; Cordell GA
    J Nat Prod; 1980; 43(1):157-61. PubMed ID: 7400819
    [No Abstract]   [Full Text] [Related]  

  • 15. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.) XII. Preparation and characterization of trace alkaloids.
    SVOBODA GH; GORMAN M; BARNES AJ; OLIVER AT
    J Pharm Sci; 1962 Jun; 51():518-23. PubMed ID: 13918739
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alkaloids of Vinca rosea L. introduced to Western Georgia].
    Vachnadze NS; Kintsurashvili LG; Suladze TSh; Bakuridze AD; Vachnadze VIu
    Georgian Med News; 2013 Nov; (224):85-8. PubMed ID: 24323972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of research on the alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don).
    SVOBODA GH; JOHNSON IS; GORMAN M; NEUSS N
    J Pharm Sci; 1962 Aug; 51():707-20. PubMed ID: 13918740
    [No Abstract]   [Full Text] [Related]  

  • 18. ASSAY METHODS FOR SOME VINCA ROSEA ALKALOIDS. II.
    JAKOVLJEVIC IM; SEAY LD; SHAFFER RW
    J Pharm Sci; 1964 May; 53():553-7. PubMed ID: 14193893
    [No Abstract]   [Full Text] [Related]  

  • 19. Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.). V. Preparation and characterization of alkaloids.
    SVOBODA GH; NEUSS N; GORMAN M
    J Am Pharm Assoc Am Pharm Assoc; 1959 Nov; 48():659-66. PubMed ID: 13854990
    [No Abstract]   [Full Text] [Related]  

  • 20. [THERAPEUTIC ACTION OF THE ALKALOIDS OF CATHARANTHUS ROSEUS (VINCA ROSEA) ON HODGKIN'S DISEASE AND ACUTE LEUKOSIS].
    CHASSAGNE P; CRUVEILLER J; GEORGES-JANET L; MARY F
    Therapie; 1964; 19():1037-46. PubMed ID: 14190930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.